Mark J. Ratain to Cell Cycle Proteins
This is a "connection" page, showing publications Mark J. Ratain has written about Cell Cycle Proteins.
Connection Strength
0.090
-
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignancies. Clin Cancer Res. 2009 Feb 15; 15(4):1428-34.
Score: 0.070
-
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010 Oct 28; 363(18):1693-703.
Score: 0.020